🔎 Trials Near Me

Home › Heart Attack › Pennsylvania

Heart Attack clinical trials in Pennsylvania

3 studies for Heart Attack are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Northeast Clinical Research Center, LLC, Bethlehem
  • Clinical Renal Associates, LTD, Exton
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Lancaster General Health, Lancaster
  • Perelman School of Medicine, Philadelphia
  • Allegheny General Hospital, Pittsburgh
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • University of Pennsylvania, Philadelphia
  • Preferred Primary Care Physicians, Inc, Pittsburgh
  • Pottstown Medical Specialists Inc, Pottstown
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.